---
figid: PMC7907897__gr2
figlink: pmc/articles/PMC7907897/figure/fig2/
number: Fig. 2
caption: NRF2 regulatory mechanisms.A) three reported negative regulatory mechanisms
  of NRF2. KEAP1 is the first and major NRF2 negative regulator in cells. In normal
  condition, KEAP1 binds to NRF2 and connects NRF2 to Cullin3 E3 ubiquitin ligase,
  leads to NRF2 degradation in proteasome. In addition, GSK-3α/β kinases can phosphorylate
  NRF2 which lets it binding to β-TrCP-Cul1 ubiquitin ligase, leads to NRF2 degradation
  in proteasome. HRD1 is a recently identified E3 ubiquitin ligase which targets NRF2
  when activated by XBP1 under ER stress. So far, this regulatory pathway has only
  been reported during liver cirrhosis. B) NRF2 activation mechanisms. When cells
  are under stresses such as electrophilic stimuli, cysteine molecules in KEAP1 are
  modified (oxidized) that leads to release of NRF2 from KEAP1-Cul3-mediated ubiquitination.
  The free and newly-synthesized NRF2 then accumulates and translocates to nucleus
  and binds to the ARE on its target genes' promotor and activates its target genes.
  So far, about 250 target genes have been reported involving Phase I-III metabolism,
  redox regulation, lipid and carbohydrate metabolism, iron/hemo metabolism and many
  other cellular processes. In addition to this canonic KEAP1 dependent mechanism,
  many non-canonic mechanisms have been reported. For example, KEAP1 genetic mutations,
  promoter hypermethylation which inactivate KEAP1, some proteins binding to KEAP1
  to interfere with KEAP-NRF2 interaction, such as p62, PALB2. Genetic mutations of
  NRF2, epigenetic regulation, phosphorylation and SUMOylation of NRF2 itself activate
  NRF2. Some proteins such as p21, BRCA1 and APE1 have been reported to bind to NRF2
  to interfere with NRF2-KEAP1 interaction. Taken together, the NRF2 is a master transcriptional
  regulator in cellular antioxidant function and other cellular processes. The regulatory
  mechanisms are complex and context-dependent.
pmcid: PMC7907897
papertitle: 'The antioxidant response in Barrett''s tumorigenesis: A double-edged
  sword.'
reftext: Dunfa Peng, et al. Redox Biol. 2021 May;41:101894.
pmc_ranked_result_index: '38326'
pathway_score: 0.9223183
filename: gr2.jpg
figtitle: NRF2 regulatory mechanisms.A) three reported negative regulatory mechanisms
  of NRF2
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7907897__gr2.html
  '@type': Dataset
  description: NRF2 regulatory mechanisms.A) three reported negative regulatory mechanisms
    of NRF2. KEAP1 is the first and major NRF2 negative regulator in cells. In normal
    condition, KEAP1 binds to NRF2 and connects NRF2 to Cullin3 E3 ubiquitin ligase,
    leads to NRF2 degradation in proteasome. In addition, GSK-3α/β kinases can phosphorylate
    NRF2 which lets it binding to β-TrCP-Cul1 ubiquitin ligase, leads to NRF2 degradation
    in proteasome. HRD1 is a recently identified E3 ubiquitin ligase which targets
    NRF2 when activated by XBP1 under ER stress. So far, this regulatory pathway has
    only been reported during liver cirrhosis. B) NRF2 activation mechanisms. When
    cells are under stresses such as electrophilic stimuli, cysteine molecules in
    KEAP1 are modified (oxidized) that leads to release of NRF2 from KEAP1-Cul3-mediated
    ubiquitination. The free and newly-synthesized NRF2 then accumulates and translocates
    to nucleus and binds to the ARE on its target genes' promotor and activates its
    target genes. So far, about 250 target genes have been reported involving Phase
    I-III metabolism, redox regulation, lipid and carbohydrate metabolism, iron/hemo
    metabolism and many other cellular processes. In addition to this canonic KEAP1
    dependent mechanism, many non-canonic mechanisms have been reported. For example,
    KEAP1 genetic mutations, promoter hypermethylation which inactivate KEAP1, some
    proteins binding to KEAP1 to interfere with KEAP-NRF2 interaction, such as p62,
    PALB2. Genetic mutations of NRF2, epigenetic regulation, phosphorylation and SUMOylation
    of NRF2 itself activate NRF2. Some proteins such as p21, BRCA1 and APE1 have been
    reported to bind to NRF2 to interfere with NRF2-KEAP1 interaction. Taken together,
    the NRF2 is a master transcriptional regulator in cellular antioxidant function
    and other cellular processes. The regulatory mechanisms are complex and context-dependent.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - XBP1
  - CUL3
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - CUL1
  - KEAP1
  - AKR1C1
  - HPGDS
  - GPX4
  - GPX2
  - ABCG2
  - ABCC4
  - ABCC5
  - ABCC2
  - ABCC3
  - ABCC1
  - FTH1
  - ADCY2
  - LIPH
  - IDH1
  - G6PD
  - GSR
  - GCLM
  - ATG7
  - ATG5
  - PSMA1
  - PSMB5
  - RAD51
  - AHR
  - NOTCH1
  - SYVN1
  - AKT2
  - AKT3
  - AKT1
  - GSK3A
  - GSK3B
  - MAF
  - BRCA1
  - AMER1
  - BRCA2
  - DPP3
  - Iron
  - Carbohydrate
genes:
- word: XBP1
  symbol: XBP1
  source: hgnc_symbol
  hgnc_symbol: XBP1
  entrez: '7494'
- word: CUL3
  symbol: CUL3
  source: hgnc_symbol
  hgnc_symbol: CUL3
  entrez: '8452'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: CUL1
  symbol: CUL1
  source: hgnc_symbol
  hgnc_symbol: CUL1
  entrez: '8454'
- word: CUL1
  symbol: CUL1
  source: hgnc_symbol
  hgnc_symbol: CUL1
  entrez: '8454'
- word: KEAP1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: KEAP1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: Phase1metabolism:NQ01,AKR1C1
  symbol: AKR1C1
  source: hgnc_symbol
  hgnc_symbol: AKR1C1
  entrez: '1645'
- word: AKR1C1
  symbol: AKR1C1
  source: hgnc_symbol
  hgnc_symbol: AKR1C1
  entrez: '1645'
- word: GSTS,
  symbol: GSTS
  source: hgnc_alias_symbol
  hgnc_symbol: HPGDS
  entrez: '27306'
- word: GPX4
  symbol: GPX4
  source: hgnc_symbol
  hgnc_symbol: GPX4
  entrez: '2879'
- word: GPX2,
  symbol: GPX2
  source: hgnc_symbol
  hgnc_symbol: GPX2
  entrez: '2877'
- word: Phase2metabolism:GSTS,GPX2,GPX4
  symbol: GPX2
  source: hgnc_symbol
  hgnc_symbol: GPX2
  entrez: '2877'
- word: Phase2metabolism:GSTS,GPX2,GPX4
  symbol: GPX4
  source: hgnc_symbol
  hgnc_symbol: GPX4
  entrez: '2879'
- word: ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: ABCC1-5,
  symbol: ABCC4
  source: hgnc_symbol
  hgnc_symbol: ABCC4
  entrez: '10257'
- word: ABCC1-5,
  symbol: ABCC5
  source: hgnc_symbol
  hgnc_symbol: ABCC5
  entrez: '10057'
- word: ABCC1-5,
  symbol: ABCC2
  source: hgnc_symbol
  hgnc_symbol: ABCC2
  entrez: '1244'
- word: ABCC1-5,
  symbol: ABCC3
  source: hgnc_symbol
  hgnc_symbol: ABCC3
  entrez: '8714'
- word: ABCC1-5,
  symbol: ABCC1
  source: hgnc_symbol
  hgnc_symbol: ABCC1
  entrez: '4363'
- word: Phase3metabolism:ABCC1-5,ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: Iron/hemometabolism:HO-1,FTH1
  symbol: FTH1
  source: hgnc_symbol
  hgnc_symbol: FTH1
  entrez: '2495'
- word: FTH1
  symbol: FTH1
  source: hgnc_symbol
  hgnc_symbol: FTH1
  entrez: '2495'
- word: ACOX1/2
  symbol: AC2
  source: hgnc_alias_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: LIPH,
  symbol: LIPH
  source: hgnc_symbol
  hgnc_symbol: LIPH
  entrez: '200879'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: G6PD,
  symbol: G6PD
  source: hgnc_symbol
  hgnc_symbol: G6PD
  entrez: '2539'
- word: Carbohydratemetabolism:G6PD,IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: GSR,
  symbol: GSR
  source: hgnc_symbol
  hgnc_symbol: GSR
  entrez: '2936'
- word: Redoxregulation:GCLM,GSR,XCT
  symbol: GSR
  source: hgnc_symbol
  hgnc_symbol: GSR
  entrez: '2936'
- word: GCLM,
  symbol: GCLM
  source: hgnc_symbol
  hgnc_symbol: GCLM
  entrez: '2730'
- word: ATG5/7
  symbol: ATG7
  source: hgnc_symbol
  hgnc_symbol: ATG7
  entrez: '10533'
- word: ATG5/7
  symbol: ATG5
  source: hgnc_symbol
  hgnc_symbol: ATG5
  entrez: '9474'
- word: PSMA1,
  symbol: PSMA1
  source: hgnc_symbol
  hgnc_symbol: PSMA1
  entrez: '5682'
- word: PSMB5
  symbol: PSMB5
  source: hgnc_symbol
  hgnc_symbol: PSMB5
  entrez: '5693'
- word: Proteasomeassembly:PSMA1,PSMB5
  symbol: PSMB5
  source: hgnc_symbol
  hgnc_symbol: PSMB5
  entrez: '5693'
- word: RAD51
  symbol: RAD51
  source: hgnc_symbol
  hgnc_symbol: RAD51
  entrez: '5888'
- word: DNAdamage:P53PB1,RAD51
  symbol: RAD51
  source: hgnc_symbol
  hgnc_symbol: RAD51
  entrez: '5888'
- word: AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: Transcriptionalregulation:Notch1,AhR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: Notch1,
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: HRD1
  symbol: HRD1
  source: hgnc_alias_symbol
  hgnc_symbol: SYVN1
  entrez: '84447'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: МAF
  symbol: MAF
  source: hgnc_symbol
  hgnc_symbol: MAF
  entrez: '4094'
- word: NRF2interactionproteins:p21,BRCA1,APE1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: BRCA1,
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: Proteininteractions:p62,DPP3,WTX,BRCA2
  symbol: WTX
  source: hgnc_alias_symbol
  hgnc_symbol: AMER1
  entrez: '139285'
- word: Proteininteractions:p62,DPP3,WTX,BRCA2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: Proteininteractions:p62,DPP3,WTX,BRCA2
  symbol: DPP3
  source: hgnc_symbol
  hgnc_symbol: DPP3
  entrez: '10072'
- word: DPP3,
  symbol: DPP3
  source: hgnc_symbol
  hgnc_symbol: DPP3
  entrez: '10072'
- word: WTX,BRCA2
  symbol: BRCA2
  source: hgnc_symbol
  hgnc_symbol: BRCA2
  entrez: '675'
- word: WTX,BRCA2
  symbol: WTX
  source: hgnc_alias_symbol
  hgnc_symbol: AMER1
  entrez: '139285'
chemicals:
- word: Iron
  source: MESH
  identifier: D007501
- word: Carbohydrate
  source: MESH
  identifier: D002241
diseases: []
---
